Jack R. Andrews

1.3k total citations
53 papers, 504 citations indexed

About

Jack R. Andrews is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Jack R. Andrews has authored 53 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 20 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Surgery. Recurrent topics in Jack R. Andrews's work include Prostate Cancer Treatment and Research (31 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Prostate Cancer Diagnosis and Treatment (17 papers). Jack R. Andrews is often cited by papers focused on Prostate Cancer Treatment and Research (31 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and Prostate Cancer Diagnosis and Treatment (17 papers). Jack R. Andrews collaborates with scholars based in United States, Italy and Switzerland. Jack R. Andrews's co-authors include B.J.M. Jones, R. E. M. Lees, P. Frost, D. B. A. Silk, R. Jeffrey Karnes, Giovanni Motterle, Stephen A. Boorjian, Christine M. Lohse, R. Houston Thompson and Bradley C. Leibovich and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gut.

In The Last Decade

Jack R. Andrews

44 papers receiving 495 citations

Peers

Jack R. Andrews
D. Jan France
Danny Lascano United States
Sung Il Choi South Korea
Sarah B. Umar United States
Young Beom Jeong South Korea
Jack R. Andrews
Citations per year, relative to Jack R. Andrews Jack R. Andrews (= 1×) peers Mehdi Abedinzadeh

Countries citing papers authored by Jack R. Andrews

Since Specialization
Citations

This map shows the geographic impact of Jack R. Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack R. Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack R. Andrews more than expected).

Fields of papers citing papers by Jack R. Andrews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack R. Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack R. Andrews. The network helps show where Jack R. Andrews may publish in the future.

Co-authorship network of co-authors of Jack R. Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Jack R. Andrews. A scholar is included among the top collaborators of Jack R. Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack R. Andrews. Jack R. Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naqvi, Syed Arsalan Ahmed, Jack R. Andrews, Alan H. Bryce, et al.. (2025). Automated risk stratification in localized prostate cancer using an AI-assisted framework.. Journal of Clinical Oncology. 43(5_suppl). 341–341.
2.
Andrews, Jack R., Aurélie De Bruycker, Ryan Phillips, et al.. (2025). PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts. Clinical Cancer Research. 31(6). 1142–1149. 5 indexed citations
3.
Ahmed, Mohamed E., Ahmed Mahmoud, Irbaz Bin Riaz, et al.. (2024). Survival Patterns Based on First-site–specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?. European Urology Open Science. 66. 38–45. 3 indexed citations
4.
Ahmed, Mohamed E., Jack R. Andrews, Ahmed Mahmoud, et al.. (2024). PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL. The Journal of Urology. 211(5S). 1 indexed citations
5.
Mahmoud, Ahmed, Mohamed E. Ahmed, Spyridon P. Basourakos, et al.. (2024). Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies. Cancers. 16(11). 2080–2080. 2 indexed citations
6.
Ahmed, Mohamed E., Jack R. Andrews, Ahmed Mahmoud, et al.. (2024). Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes. The Journal of Urology. 213(4). 447–454. 1 indexed citations
7.
Mahmoud, Ahmed, Cameron J. Britton, Vidit Sharma, et al.. (2024). In‐field prostate cancer recurrence following radical prostatectomy and salvage radiation. British Journal of Urology. 135(4). 668–674.
8.
Mahmoud, Ahmed, Mohamed E. Ahmed, A. Tuba Kendi, et al.. (2023). Low PSA radiographic disease progression on C11‐choline PET. SHILAP Revista de lepidopterología. 5(2). 319–324. 1 indexed citations
9.
Mahmoud, Ahmed, Robert W. Gao, Mohamed E. Ahmed, et al.. (2023). Metastasis-Directed Therapy for Metachronous Lung Metastases in Prostate Cancer. JU Open Plus. 1(10). 2 indexed citations
10.
Mahmoud, Ahmed, Daniel S. Childs, Mohamed E. Ahmed, et al.. (2023). Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis. The Prostate. 84(3). 237–244. 2 indexed citations
11.
Sood, Anil K., Ashutosh Tewari, Ashok K. Hemal, et al.. (2023). 15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer. Prostate Cancer and Prostatic Diseases. 26(4). 778–786. 5 indexed citations
12.
Ahmed, Mohamed E., Ahmed Mahmoud, Raevti Bole, et al.. (2023). Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 27(2). 334–338. 1 indexed citations
13.
Ahmed, Mohamed E., Raevti Bole, Jack R. Andrews, et al.. (2023). High-volume mCRPC is associated with decreased cancer specific survival in patients on second-generation hormone therapy in the post docetaxel setting.. Journal of Clinical Oncology. 41(6_suppl). 192–192. 1 indexed citations
14.
Andrews, Jack R., Christine M. Lohse, Stephen A. Boorjian, et al.. (2022). Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 40(4). 166.e1–166.e8. 5 indexed citations
15.
Boswell, Timothy, et al.. (2021). Robotic Puboprostatic Fistula Repair with Holmium Laser Pubic Debridement. Urology. 160. 228–228. 3 indexed citations
16.
Westerman, Mary E., Francisco Galindo, Jack R. Andrews, et al.. (2020). Intercourse frequency among men presenting to a sexual health clinic: does age matter?. International Journal of Impotence Research. 33(1). 49–54. 2 indexed citations
17.
Motterle, Giovanni, Jack R. Andrews, Alessandro Morlacco, & R. Jeffrey Karnes. (2019). Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer. European Urology Focus. 6(4). 642–649. 41 indexed citations
18.
Ahmed, Mohamed E., Giovanni Motterle, Jack R. Andrews, et al.. (2019). Salvage Radical Prostatectomy After Robot-assisted Laparoscopic Prostatectomy: Case Series. Clinical Genitourinary Cancer. 18(2). e202–e207.
19.
Andrews, Jack R., et al.. (2018). Artificial urinary sphincter revision with Quick Connects® versus suture−tie connectors: does technique make a difference?. SHILAP Revista de lepidopterología. 45(4). 284–288.
20.
Martin, Aaron D., Rafael N. Nuñez, Jack R. Andrews, et al.. (2009). Outpatient Prostatectomy: Too Much Too Soon or Just What the Patient Ordered. Urology. 75(2). 421–424. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026